EUVIMEDEUVIMED entdecken
Open Access

Effect of proinflammatory cytokines on intestinal drug transporters in human enteroid monolayers

Kai Wang, Yik Pui Tsang, Kenneth E Thummel, Edward J Kelly, Qingcheng Mao, Jashvant D Unadkat

Drug Metabolism and Disposition · 2026

DOI: 10.1016/j.dmd.2025.100208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026. Verfasst von Kai Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington. Hauptthemen laut MEDLINE: Cytokines, Intestinal Mucosa, Membrane Transport Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NICHD NIH HHS, Johns Hopkins University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Altered drug pharmacokinetics during inflammation or infection have been linked to elevated plasma concentrations of proinflammatory cytokines. Data on how these cytokines affect the expression and activity of intestinal drug transporters and, therefore, bioavailability of transported drugs, remain limited. Here, we used a novel human enteroid in vitro model to investigate the effects of key proinflammatory cytokines (ie, interleukin [IL]-1β, IL-6, tumor necrosis factor-α, and interferon-gamma) on the mRNA expression of major intestinal transporters and activity of intestinal breast cancer resistance protein (BCRP) and P-glycoprotein (P-gp). Differentiated enteroid monolayers (in 96-well plates) were treated for 48 hours with each cytokine individually or in combination (cocktail) at 0.1, 1, or 10 ng/mL, encompassing their pathophysiological plasma concentrations in various inflammatory conditions. In a concentration-dependent manner, the cytokine cocktail significantly reduced the mRNA expression of BCRP, P-gp, multidrug resistance proteins 2/3, organic solute transporter α/β, serotonin transporter, and organic anion transporter polypeptide 2B1, while increasing multidrug resistance protein4 mRNA expression. Among individual cytokines, IL-1β elicited the most pronounced effects. To quantify the effect of cytokines on mRNA expression and activity of BCRP and P-gp, these treatments, at 1 ng/mL of individual cytokines or the cocktail, were repeated in the Transwell format. The efflux ratio of nitrofurantoin (a selective BCRP substrate), after exposure to 1 ng/mL of each cytokine or the cytokine cocktail for 48 hours, was significantly reduced, whereas the efflux ratio of digoxin (a P-gp substrate) remained unchanged. SIGNIFICANCE STATEMENT: Proinflammatory cytokines significantly downregulate major intestinal drug transporter expression and breast cancer resistance protein activity in human enteroid monolayers, highlighting the potential impact of inflammation on oral drug bioavailability. These results can be used to populate physiologically-based pharmacokinetic models to predict transporter-mediated drug absorption under inflammatory conditions, guiding safer and more effective dosing regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesIntestinal MucosaMembrane Transport ProteinsHumansATP Binding Cassette Transporter, Subfamily G, Member 2ATP Binding Cassette Transporter, Subfamily B, Member 1RNA, MessengerNeoplasm ProteinsInflammationBiological TransportATP-Binding Cassette TransportersDigoxin

Stichwörter der Autor:innen

Disease-drug interactionsDrug absorptionIntestinal drug transportersIntestinal organoidsProinflammatory cytokinesTransporter regulation

Substanzen

CytokinesATP Binding Cassette Transporter, Subfamily G, Member 2ABCG2 protein, humanATP Binding Cassette Transporter, Subfamily B, Member 1RNA, MessengerMembrane Transport ProteinsNeoplasm ProteinsATP-Binding Cassette TransportersDigoxin

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington.
  • Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington; Kidney Research Institute, University of Washington, Seattle, Washington.
  • Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington. Electronic address: jash@uw.edu.

Förderung

  • NIDA NIH HHS
  • NICHD NIH HHS
  • Johns Hopkins University
  • National Institute of Child Health and Human Development

Zitieren

APA

Wang, K., Tsang, Y. P., Thummel, K. E., Kelly, E. J., Mao, Q., & Unadkat, J. D. (2026). Effect of proinflammatory cytokines on intestinal drug transporters in human enteroid monolayers. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100208

Vancouver

Wang K, Tsang YP, Thummel KE, Kelly EJ, Mao Q, Unadkat JD. Effect of proinflammatory cytokines on intestinal drug transporters in human enteroid monolayers. Drug Metabolism and Disposition. 2026. doi:10.1016/j.dmd.2025.100208

BibTeX
@article{Wang2026,
  author = {Wang, Kai and Tsang, Yik Pui and Thummel, Kenneth E and Kelly, Edward J and Mao, Qingcheng and Unadkat, Jashvant D},
  title = {Effect of proinflammatory cytokines on intestinal drug transporters in human enteroid monolayers},
  journal = {Drug Metabolism and Disposition},
  year = {2026},
  doi = {10.1016/j.dmd.2025.100208}
}
Kostenlos starten →